Advertisement
Advertisement
U.S. markets open in 8 hours 26 minutes
Advertisement
Advertisement
Advertisement
Advertisement

MaxCyte, Inc. (MXCT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
6.12+0.01 (+0.16%)
At close: 01:00PM EST
5.90 -0.22 (-3.59%)
After hours: 03:56PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close6.11
Open6.18
Bid0.00 x 800
Ask0.00 x 800
Day's Range6.04 - 6.23
52 Week Range3.36 - 11.56
Volume54,586
Avg. Volume497,636
Market Cap632.067M
Beta (5Y Monthly)0.96
PE Ratio (TTM)N/A
EPS (TTM)-0.17
Earnings DateNov 09, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for MXCT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MaxCyte, Inc.
    Analyst Report: Thermo Fisher Scientific Inc.Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2022 (revenue figures include some cross-segment revenue): analytical technologies (15% of sales); specialty diagnostic products (10%); life science solutions (30%); and lab products and services, which includes CRO services (51%).
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
Advertisement
Advertisement